What President Trump’s Fertility Care Announcement Means for RMG Patients

On October 16, President Trump announced a new set of initiatives aimed at expanding access to fertility care and reducing fertility treatment costs in the United States. These proposals include discounted fertility medications, employer benefit guidance, and expedited drug approvals. 

For the most up-to-date information, we encourage you to visit the Prelude Network website as updates become available. 

Quick Facts About the New IVF Initiative 

• Discounted IVF Medications via TrumpRx. A new government-backed platform, TrumpRx.gov, will launch in January 2026, offering discounts on three commonly prescribed IVF medications from EMD Serono including Gonal-f®, Ovidrel®, and Cetrotide®. 

• Employer Fertility Benefits. The federal government is encouraging employers to offer standalone infertility benefits—similar to dental or vision plans—through newly issued guidance. However, these benefits will remain optional, with no federal mandate or financial support attached. 

• FDA Fast-Tracking Drug Approval. EMD Serono’s fertility drug Pergoveris, will undergo priority review by the FDA to expedite its availability in the U.S.  

What This Means for Patients at The Reproductive Medicine Group 

While these initiatives are promising, they are not yet active. Here’s what you need to know as we look ahead to 2026: 

• If you’re currently in treatment: Your medication plan will remain unchanged. Once the discount begins, our team will help you determine if future cycles qualify for discounted pricing. 

• If you’re planning IVF: Medication costs may decrease in 2026. We’ll keep you informed as TrumpRx becomes available and pricing details are finalized. 

• If your employer offers insurance: More companies may begin offering fertility benefits.  

• For all patients: Lower medication prices and expanded coverage could make IVF more accessible for many families. We’ll continue to monitor these developments and share updates as they unfold. 

What to Keep in Mind 

• The TrumpRx program is not yet live. It is expected to launch in January 2026, but no exact date has been confirmed. 

• Discounts apply only to specific EMD Serono medications, which may not be used in every fertility treatment plan. 

The Reproductive Medicine Group will continue to provide transparent guidance and support as these changes take shape. 

For more details, see: Reuters — White House set to announce proposal seeking to make IVF more accessible